论文信息 - Supporting Women's Autonomy in Prenatal Testing.

Supporting Women's Autonomy in Prenatal Testing.

Current prenatal screening practices and the complexity of genomic science create a risk that early, noninvasive fetal genetic sequencing will be integrated into care without the robust informed consent processes necessary for respecting women’s autonomy.

E. Parens | R. Farrell | J. Johnston

[1] M. Allyse,et al. Expanding Use of cfDNA Screening in Pregnancy: Current and Emerging Ethical, Legal, and Social Issues , 2017, Current Genetic Medicine Reports.

[2] Ripudaman Singh,et al. Genome‐wide copy number analysis on DNA from fetal cells isolated from the blood of pregnant women , 2016, Prenatal diagnosis.

[3] Michael J Ackerman,et al. The Promise and Peril of Precision Medicine: Phenotyping Still Matters Most. , 2016, Mayo Clinic proceedings.

[4] S. Gregorich,et al. Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial. , 2014, JAMA.

[5] B. Bernhardt,et al. Women’s experiences receiving abnormal prenatal chromosomal microarray testing results , 2012, Genetics in Medicine.